86.92 USD
↘ 3.98 (4.38%)AT CLOSE (11:59 AM EDT)
Apogee Therapeutics, Inc. Common Stock
APGENASDAQ • USD
86.89
↘ 0.04 (0.04%)
POST MARKET (AS OF 07:00 PM EDT)
Post Market
AS OF 07:00 PM EDT
86.89
↘ 0.04 (0.04%)
Market: CLOSED
Open?$90.00
High?$91.90
Low?$85.75
Prev. Close?$90.90
Volume?1.3M
Avg. Volume?877.0K
VWAP?$87.18
Rel. Volume?1.49x
Bid / Ask
Bid?$75.17 × 100
Ask?$99.34 × 100
Spread?$24.17
Midpoint?$87.26
Valuation & Ratios
Market Cap?6.6B
Shares Out?61.9M
Float?55.6M
Float %?81.5%
P/E Ratio?N/A
P/B Ratio?5.22
EPS?-$3.64
Dividend?0.00%
Ex-Dividend?N/A
Shares of Apogee Therapeutics, Inc. Common Stock (APGE) are trading at $86.92. Our models show a "Strong Buy" technical signal alongside a "Neutral" fundamental rating. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. APGE is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Jun 5, 2026.
News
Profile
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
Employees
261
Market Cap
6.6B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2023-07-14
Address
221 CRESCENT ST.
WALTHAM, MA 02453
Phone: 650-394-5230
WALTHAM, MA 02453
Phone: 650-394-5230
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?50
Short Sent.?39
Piotroski F-Score?0/9Weak
Altman Z-Score?103.34Safe
Confidence?49%Low
Short InterestVery High
Short % of Float?16.84%High
Short Interest?9.4M
Days to Cover?15.9
Free Float55.6M
Avg Daily Volume591.1K
Settlement Date2026-05-15
Financial Health
Current Ratio?32.59Strong
Quick Ratio?32.59Strong
Cash Ratio?13.71Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?5.22FAIR▾
Peers100
S&P35
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-20.3CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-21.9%WEAK▾
S&P7
ROA?-21.2%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-235373000
Enterprise Value?$6.1B
Fundamentals ratios updated end of day